In the BioHarmony Drug Report Database

"Preview" Icon

Plazomicin

Zemdri (plazomicin) is a small molecule pharmaceutical. Plazomicin was first approved as Zemdri on 2018-06-25. It is used to treat escherichia coli infections, pyelonephritis, and urinary tract infections in the USA. Zemdri (plazomicin)’s patents are valid until 2031-06-02 (FDA).

 

Trade Name

 

Zemdri
 

Common Name

 

plazomicin
 

ChEMBL ID

 

CHEMBL1650559
 

Indication

 

escherichia coli infections, pyelonephritis, urinary tract infections
 

Drug Class

 

Antibiotics (Micromonospora strains)

Image (chem structure or protein)

Plazomicin structure rendering